AVNS on NYSE

Avanos Medical

Logo: Avanos Medical, Public domain, via Wikimedia Commons4

American medical technology company

Avanos Medical, Inc. is a medical technology company making clinical medical devices.3 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

2014Founded1

Compare with Invacare, Cadre Holdings, Inc. or Bone Biologics Corp, or pick any stock.

  • TickerAVNS on NYSE1
  • Industryhealth care1
  • HeadquartersAlpharetta1
  • Websitewww.avanos.com
  • Legal formDelaware corporation1
  • Incorporated inDE5
  • Business address5405 Windward Parkway, Suite 100 South, Alpharetta, Ga 300045
  • Filer categoryLarge accelerated filer5

Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

50.5%Gross margin7
-8.8%Operating margin7
-10.4%Net margin7
1.9%Revenue growth, 20257
-9.4%Return on equity7
0.12×Debt to equity7

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue50¢$347.3M
  • Research and development3¢$23.3M
  • Selling, general and admin45¢$315.6M
  • Other costs1¢$8.3M
  • Income tax1¢$6.7M

Out of $701.2M in revenue.7 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Share buybacks4¢$3.3M
  • Kept or used elsewhere96¢$71.4M

Out of $74.7M of cash from operations.7

Financial statements

Revenue8910117$701.2M in 2025+1% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $697.6M$697.6M20192020: $714.8M$714.8M2020+2%2021: $587.0M$587.0M2021−18%2022: $684.1M$684.1M2022+17%2023: $673.3M$673.3M2023−2%2024: $687.8M$687.8M2024+2%2025: $701.2M$701.2M2025+2%
Gross profit8910117$353.9M in 2025−12% since 2019
0$200.0M$400.0M$600.0M2019: $402.2M$402.2M20192020: $370.9M$370.9M2020−8%2021: $299.2M$299.2M2021−19%2022: $394.2M$394.2M2022+32%2023: $379.7M$379.7M2023−4%2024: $381.3M$381.3M2024+0%2025: $353.9M$353.9M2025−7%
Operating income8910117-$61.6M in 2025+11% since 2019
-$400.0M-$200.0M0$200.0M2019: -$55.7M-$55.7M20192020: -$48.5M-$48.5M2020−13%2021: -$39.0M-$39.0M2021−20%2022: $35.5M$35.5M20222023: $4.2M$4.2M2023−88%2024: -$396.2M-$396.2M20242025: -$61.6M-$61.6M2025−84%
Net income8910117-$72.9M in 2025+59% since 2019
-$400.0M-$200.0M0$200.0M2019: -$45.9M-$45.9M20192020: -$29.0M-$29.0M2020−37%2021: $6.3M$6.3M20212022: $50.5M$50.5M2022+702%2023: -$61.8M-$61.8M20232024: -$392.1M-$392.1M2024+534%2025: -$72.9M-$72.9M2025−81%
Fiscal year2019202020212022202320242025
Revenue$697.6M8$714.8M9$587.0M10$684.1M11$673.3M7$687.8M7$701.2M7
Cost of revenue$295.4M8$343.9M9$287.8M10$289.9M11$293.6M7$306.5M7$347.3M7
Gross profit$402.2M8$370.9M9$299.2M10$394.2M11$379.7M7$381.3M7$353.9M7
Research and development$37.7M8$34.9M9$30.6M10$29.2M11$27.2M7$26.2M7$23.3M7
Selling, general and admin$399.1M8$332.6M9$285.3M10$326.5M11$335.0M7$318.5M7$315.6M7
Operating income-$55.7M8-$48.5M9-$39.0M10$35.5M11$4.2M7-$396.2M7-$61.6M7
Interest$15.0M8$15.6M9$3.3M10$10.0M10$15.0M10
Income tax-$18.1M8-$33.9M9-$11.2M10$5.2M11$2.0M7-$17.0M7$6.7M7
Net income-$45.9M8-$29.0M9$6.3M10$50.5M11-$61.8M7-$392.1M7-$72.9M7
Earnings per share-$0.968-$0.619$0.1310$1.0811-$1.327-$8.537-$1.577
Earnings per share (diluted)-$0.968-$0.619$0.1310$1.0711-$1.327-$8.537-$1.577

Compare Avanos Medical with another company

The story

Avanos Medical also manufactures and distributes Eternal Access System to help healthcare providers to fit feeding tubes into a patient safely - that is the Cortak 2.

They describe Cortrak 2 system as "a time-saving solution that benefits nurses of all levels, dieticians, and GI and ICU doctors."

In April 2022, it was reported that a voluntary field correction had been issued by the company for a vital hospital tool that could have led to injury or even death.

Avanos sells its brands and products in more than 90 countries and operates 8 principal medical device production facilities – generating approximately $612 million in net revenue.

In April 2026, Avanos agreed to be acquired by affiliates of American Industrial Partners. The acquisition was completed in July 2026.

From Wikipedia’s article on Avanos Medical, shared under CC BY-SA 4.0.6

Former names

  • Halyard Health, Inc.May 6, 2014 to Jun 28, 20185

Timeline

  1. 2014Founded Founded1

Recent filings

  1. Jul 30, 20268-K
  2. Jul 28, 20264
  3. Jul 28, 20264
  4. Jul 28, 20264
  5. Jul 28, 20264
  6. Jul 28, 20264
  7. Jul 28, 20264
  8. Jul 28, 20264
  9. Jul 28, 20264
  10. Jul 22, 20268-K
  11. Jul 15, 20268-K
  12. Jul 2, 20268-K
  13. May 12, 20264
  14. May 12, 20264
  15. May 12, 20264

Every filing from the last three years, summarized. The full record is on SEC EDGAR.2